End Stage Renal Disease Clinical Trials
19 studies are recruiting for end stage renal disease in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
By city
Studies now recruiting
-
Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry
Post market registry to assess the safety and efficacy of a novel decellularized human femoral artery allograft (Nexeon AVX Decellularized Femoral Artery,
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Infirmary Heath, Mobile, Alabama
- Locations
- 4 in total
- Run by
- LifeNet Health
-
Partners Calciphylaxis Biobank
Calciphylaxis, a vascular calcification disorder, is a rare and serious disorder characterized by calcification of dermal arterioles. There are significant gaps in the understanding of the pathophysiology and risk factors for calciphylaxis. At present, there is no effective treatment. Uncertain pat…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Massachusetts General Hospital, Boston, Massachusetts
- Run by
- Massachusetts General Hospital
-
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
A prospective, single-arm, multi-center post-market surveillance study of the BD® WavelinQ™ EndoAVF System for the Creation of Arteriovenous (AV) Fistula in Patients Requiring Dialysis.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- California Institute of Renal Research, La Jolla, California
- Locations
- 17 in total
- Run by
- C. R. Bard
-
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
Kidney failure has been recognized as one of the most costly chronic conditions among United States Veterans. Approximately 13,000 Veterans develop kidney failure each year, and most require hemodialysis initiation. Hemodialysis patients suffer significantly increased risk of death and hospitalizat…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas, Texas
- Run by
- VA Office of Research and Development
-
CAPABLE Transplant
The purpose of this mixed methods study is to adapt CAPABLE as CAPABLE Transplant to accomplish two things: 1) To resolve barriers to being classified as active on the Kidney Transplant (KT) waitlist, 2) as a surgical prehabilitation intervention targeting the pre-frail/ frail KT waitlist populatio…
- Stage
- Not phased
- Ages
- 18 to 99
- Site
- Johns Hopkins School of Nursing, Baltimore, Maryland
- Run by
- Johns Hopkins University
-
Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula
VasQ is an external support implant for arteriovenous fistulas created for dialysis access. This is a postmarket surveillance, prospective, multi-center, randomized, controlled, open label trial enrolling 300 patients randomized into two study arms: * Treatment arm: End to side fistula supported wi…
- Stage
- Not phased
- Ages
- 18 to 80
- Site
- Fresenius Vascular Care Long Beach, Long Beach, California
- Locations
- 9 in total
- Run by
- Laminate Medical Technologies
-
AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses
Researchers are evaluating the safety of allogeneic Adipose Derived Mesenchymal Stem Cells (AMSC) use during hemodialysis arteriovenous fistula and arterial bypass creation and its efficacy on improving access maturation and primary anastomotic patency.
- Stage
- Phase 1
- Ages
- 18 to 85
- Site
- Mayo Clinic in Florida, Jacksonville, Florida
- Run by
- Houssam Farres, M.D.
-
PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
The goal of this observational study is to increase the understanding of the safety and performance of Merit Medical's HeRO Graft System (HeRO) and Super HeRO Adaptor and Support Seal System (Super HeRO) devices. This study includes adults that are being treated with one of these devices as part of…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- MedStar Washington Hospital Center, Washington D.C., District of Columbia
- Locations
- 7 in total
- Run by
- Merit Medical Systems, Inc.
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
This is a prospective, multi-center, two-arm, randomized trial to quantify the performance of the EchoMark®/EchoSure® System for AVF diagnostic ultrasound when used under a protocol of biweekly use for assessing fistula maturation and reducing time to Clinical Maturation.
- Stage
- Not phased
- Ages
- 18 to 84
- Site
- Trinity Research Group, Dothan, Alabama
- Locations
- 21 in total
- Run by
- Sonavex, Inc.
-
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
This will be a single center, prospective, open-label, randomized, controlled trial comparing Envarsus XR® to twice-daily tacrolimus. The targeted population will be patients with end stage renal disease listed for primary solitary kidney transplant. Transplant Surgery is not part of the study.
- Stage
- Phase 2
- Ages
- 18 to 75
- Site
- Deepa Valvi, Lexington, Kentucky
- Run by
- Roberto Gedaly
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
This is a prospective, randomized, multi-center clinical trial for chronic kidney disease (CKD) patients referred for creation of a new arteriovenous fistula (AVF) in order to assess the safety and effectiveness of SelfWrap, a bioabsorbable perivascular wrap.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- AKDHC Bullhead City, Bullhead City, Arizona
- Locations
- 28 in total
- Run by
- VenoStent
-
Drug Interaction Potential of Pro-Inflammatory Conditions
Pro-inflammatory cytokines, which are elevated in pro-inflammatory disease states (e.g., type II diabetes mellitus [T2DM], irritable bowel diseases [IBD], and end stage renal disease [ESRD]) have been shown to inhibit hepatic drug-metabolizing enzymes, including members of the cytochrome P450 (CYP)…
- Stage
- Not phased
- Ages
- 12 to 99
- Site
- Indiana University Hospital, Indianapolis, Indiana
- Run by
- Indiana University
-
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
The investigators aim to determine, using a point-of-care randomized controlled trial design, if hemodialysis patients, who are randomized to metoprolol succinate (a dialyzable, beta-1 selective beta blocker), have an improved cardiovascular outcome compared to those randomized to carvedilol (a non…
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- VA Long Beach Healthcare System, Long Beach, CA, Long Beach, California
- Locations
- 8 in total
- Run by
- VA Office of Research and Development
-
CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease
Frailty and sarcopenia are modifiable risk factors for morbidity and mortality in patients with ESRD. Exercise is the recommended intervention to prevent frailty and sarcopenia, however, many clinical trials have shown limited clinical improvement in muscle mass and physical function. We propose th…
- Stage
- Phase 3
- Ages
- 18 to 75
- Site
- Vanderbilt University Medical Center-GCRC, Nashville, Tennessee
- Locations
- 2 in total
- Run by
- Vanderbilt University Medical Center
-
Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
The aim of this study is to evaluate DCR-PHXC in participants with PH1 and severe renal impairment, with or without dialysis.
- Stage
- Phase 2
- Ages
- Any age
- Site
- Clinical Trial Site, Rochester, Minnesota
- Locations
- 18 in total
- Run by
- Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
-
Safety and Efficacy of Empagliflozin in Hemodialysis
A 12-week, phase II, randomized, double-blind, placebo-controlled, multi-center study to assess the safety, tolerability, and preliminary efficacy of empagliflozin versus placebo among patients initiating hemodialysis (n=60) for the treatment of end-stage kidney disease.
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- Brigham and Women's Hospital, Boston, Massachusetts
- Locations
- 2 in total
- Run by
- NYU Langone Health
-
Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis
Hemodialysis represents a life line of patients with end stage renal disease, who are commonly maintained on hemodialysis through catheters. Prolonged exposure to these catheters eventually damages the walls of veins, which results in stenosis at the local site. This condition is called central ven…
- Stage
- Not phased
- Ages
- 18 to 85
- Site
- Boston Medical Center, Boston, Massachusetts
- Run by
- Boston Medical Center
-
Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors
This study utilizes a web-based application to help patients on the organ transplant waitlist communicate patient's need for a living donor via social media and provide interested potential donors the opportunity to engage with the evaluation process.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- The Johns Hopkins Hospital, Baltimore, Maryland
- Locations
- 6 in total
- Run by
- Johns Hopkins University
-
Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive Donors
The U.S. Department of Health and Human Services (HHS), through the National Institutes of Health (NIH), published Final Human Immunodeficiency Virus (HIV) Organ Policy Equity (HOPE) Act Safeguards and Research Criteria for Transplantation of Organs Infected With HIV. All such transplants must occu…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- East Jefferson General Hospital, Metairie, Louisiana
- Run by
- Tulane University
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.